435 (Metformin 850 mg)

Pill imprint 435 has been identified as Metformin hydrochloride 850 mg.

Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 850 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 435

Metformin hydrochloride 850 mg 435
Metformin hydrochloride 850 mg 435  Front
Metformin hydrochloride 850 mg 435  Back
Metformin hydrochloride 850 mg 435
Metformin hydrochloride
Imprint:
435
Strength:
850 mg
Color:
White
Size:
12.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Caraco Pharmaceutical Laboratories
National Drug Code (NDC):
57664-0435
Inactive Ingredients:
povidone
polyethylene glycol
magnesium stearate
lactose monohydrate
hypromellose
titanium dioxide
triacetin
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
63739-0300 McKesson Packaging Services
67544-0107 Prepak Systems Inc (repackager)
55887-0614 Diversified Healthcare Services Inc (repackager)
21695-0472 Rebel Distributors Corp (repackager)
55289-0934 PDRX Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)